United Therapeutics Corporation · NASDAQ:UTHR

Mahon Paul A sold 8,300 United Therapeutics Corporation shares (Form 4)

Traded Aug 20, 2026 · Filed Aug 21, 2026

On Aug 20, 2026, Mahon Paul A (EVP & GENERAL COUNSEL) sold 8,300 United Therapeutics Corporation shares at an average US$523.14 for US$4.34M under a trading plan, leaving 45,172 shares. Filed Aug 21, 2026 (Form 4).

Sold
8,300 shares
Price
US$523.14 average (US$520.03 to US$527.21)
Value
US$4.34M
Holding after
45,172 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EVP & GENERAL COUNSEL

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 20, 2026Common StockOption exercise2,690US$146.0347,862Direct
Aug 20, 2026Common StockOption exercise5,610US$146.0353,472Direct
Aug 20, 2026Common StockSale2,690US$524.1550,782Direct
Aug 20, 2026Common StockSale502US$520.0350,280Direct
Aug 20, 2026Common StockSale1,819US$521.0448,461Direct
Aug 20, 2026Common StockSale787US$522.0047,674Direct
Aug 20, 2026Common StockSale850US$522.7846,824Direct
Aug 20, 2026Common StockSale192US$523.6946,632Direct
Aug 20, 2026Common StockSale940US$525.2545,692Direct
Aug 20, 2026Common StockSale400US$526.3945,292Direct
Aug 20, 2026Common StockSale120US$527.2145,172Direct

Source

View original at SEC

Related